---
title: "Insider Shake-Up at Merit Medical Systems as Top Executives Trade Shares"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/286025578.md"
description: "Merit Medical Systems (MMSI) experienced significant insider trading on May 11, 2026, with Chief Legal Officer Brian G. Lloyd purchasing 2,000 shares for $125,240, indicating confidence in the company. Conversely, Director Lynne Ward sold 5,000 shares for $313,000. Despite strong Q1 results, analysts have trimmed price targets due to sector-wide issues and governance concerns. Spark's AI Analyst rates MMSI as Neutral, citing solid financial performance but weak technical conditions and a high valuation. The stock has declined 30.49% year-to-date, with a market cap of $3.66B."
datetime: "2026-05-12T02:12:47.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/286025578.md)
  - [en](https://longbridge.com/en/news/286025578.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/286025578.md)
---

# Insider Shake-Up at Merit Medical Systems as Top Executives Trade Shares

New insider activity at Merit Medical Systems ( (MMSI) ) has taken place on May 11, 2026.

### Claim 55% Off TipRanks

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks

Merit Medical Systems has seen notable insider activity, with Chief Legal Officer and Secretary Brian G. Lloyd purchasing 2,000 shares of company stock in a transaction valued at $125,240, signaling confidence in the firm’s prospects. In contrast, Director Lynne Ward sold 5,000 shares of Merit Medical Systems stock for a total of $313,000, trimming her position while adding to recent insider trading dynamics at the company.

**Recent Updates on MMSI stock**

Merit Medical shares saw active coverage as multiple firms trimmed price targets despite strong Q1 results, citing sector-wide multiple compression, slightly slower organic growth and a back-end loaded growth ramp that could weigh on near-term sentiment. Analysts still pointed to solid margin expansion, robust cash generation and expectations for sequential acceleration, while governance concerns arose over richer executive contracts and concentrated equity awards that may increase costs and dilute shareholders if performance lags.

**Spark’s Take on MMSI Stock**

According to Spark, TipRanks’ AI Analyst, MMSI is a Neutral.

The score is supported primarily by solid underlying financial performance (notably strong free cash flow and improved margins) and generally constructive guidance from the latest earnings call. It is held back by weak technical conditions (downtrend with negative momentum) and a valuation that appears moderately demanding at ~25x earnings without a stated dividend yield.

To see Spark’s full report on MMSI stock, click here.

**More about Merit Medical Systems**

**YTD Price Performance:** -30.49%

**Average Trading Volume:** 809,303

**Technical Sentiment Signal:** Sell

**Current Market Cap:** $3.66B

### Related Stocks

- [MMSI.US](https://longbridge.com/en/quote/MMSI.US.md)

## Related News & Research

- [Merit Medical’s Revised Executive Pay Deals Raise Dilution, Governance and M&A Flexibility Concerns](https://longbridge.com/en/news/284957396.md)
- [Merit Medical to Participate in the Bank of America Healthcare Conference | MMSI Stock News](https://longbridge.com/en/news/285733724.md)
- [09:00 ETMercy Names New Senior Vice President and Chief People Officer](https://longbridge.com/en/news/286775735.md)
- [Sharon AI Appoints Mr. Andrew Penn as Chairman of the Board of Directors | SHAZ Stock News](https://longbridge.com/en/news/287210261.md)
- [How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here](https://longbridge.com/en/news/286786866.md)